Carnitine palmitoyltransferase-II inactivity promotes malignant progression of metabolic dysfunction-associated fatty liver disease <i>via</i> liver cancer stem cell activation
CPT-II inactivity promotes the malignant progression of MAFLD <i>via</i> the loss of innate immune function and abnormal LCSC activation.
Authors
- Min Yao (ORCID: https://orcid.org/0000-0002-5473-0186)
- Dengfu Yao (ORCID: https://orcid.org/0000-0002-3448-7756)
- Lingling Wang (ORCID: https://orcid.org/0000-0003-0272-2974)
- Yifan Wang (ORCID: https://orcid.org/0000-0001-9966-682X)
- Yihan Wang (ORCID: https://orcid.org/0000-0002-1163-4610)
- Yuming Lu (ORCID: https://orcid.org/0000-0003-2148-9987)
- Wenli Sai (ORCID: https://orcid.org/0000-0002-9618-2720)
- Rong-Fei Fang
Institutions
- Nantong University (CN)
- Affiliated Hospital of Nantong University (CN)
Publication Details
- Journal
- World Journal of Gastroenterology
- Published
- 2024-11-25
- DOI
- https://doi.org/10.3748/wjg.v30.i47.5055
- Citations
- 2
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.77